Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2908-2915

  Hernández, Domingo ^a,b   Rufino, Margarita ^a,b   Armas, Silvia ^a   González, Ana ^a   Gutiérrez, Pedro ^a,b   Barbero, Pablo ^a   Vivancos, Sofía ^a   Rodríguez, Concepción ^a   de Vera, José Rodríguez ^a   Torres, Armando ^a,b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Immuno suppression; Kidney transplantation; Surgical complications

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; T LYMPHOCYTE ANTIBODY; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLEEDING; CADAVER KIDNEY; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DIALYSIS; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; GRAFT FAILURE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL RISK; SURGICAL TECHNIQUE; URETER OBSTRUCTION; URINE INCONTINENCE; WOUND DEHISCENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CADAVER; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33749601684     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl338     Document Type: Article

References (20)

1. Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial 2005; 18: 505-510
2. Hernández D, Rufino M, Bartolomei S et al. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int 2005; 67: 2015-2020
3. Flechner SM, Zhou L, Derweesh I et al. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 2003; 76: 1729-1734
4. Valente JF, Hricik D, Weigel K et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003; 3: 1128-1134
5. Goel M, Flechner SM, Zhou L et al. The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation. J Urol 2004; 171: 1788-1792
6. Shoskes DA, Hanbury D, Cranston D, Morris PJ. Urological complications in 1,000 consecutive renal transplant recipients. J Urol 1995; 153: 18-21
7. Osman Y, Shokeir A, Ali-el-Dein B et al. Vascular complications after live donor renal transplantation: Study of risk factors and effects on graft and patient survival. J Urol 2003; 169: 859-862
8. Humar A, Ramcharan T, Denny R et al. Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation 2001; 72: 1920-1923
9. Bakir N, Sluiter WJ, Ploeg RJ et al. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11: 140-147
10. Englesbe MJ, Punch JD, Armstrong DR et al. Single-center study of technical graft loss in 714 consecutive renal transplants. Transplantation 2004; 78: 623-626
11. Hernández D, Rufino M, Bartolomei S et al. A novel prognostic index for mortality in renal transplant recipients after hospitalization. Transplantation 2005; 79: 337-343
12. Shokeir AA, Osman Y, Ali-El-Dein B et al. Surgical complications in live-donor pediatric and adolescent renal transplantation: Study of risk factors. Pediatr Transplant 2005; 9: 33-38
13. Galazka Z, Szmidt J, Nazarewski S et al. Long-term results of kidney transplantation in recipients with atherosclerotic iliac arteries. Transplant Proc 2002; 34: 604-605
14. Buturovic-Ponikvar J. Renal transplant artery stenosis. Nephrol Dial Transplant 2003; 18 [Suppl 5]: S74-S77
15. Wong W, Fynn SP, Higgins RM et al. Transplant renal artery stenosis in 77 patients-does it have an immunological cause? Transplantation 1996; 61: 215-219
16. Singh A, Stablein D, Tejani A. Risk factors for vascular thrombosis in pediatric renal transplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997; 63: 1263-1267
17. Mangus RS, Haag BW. Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: A metaanalysis. Am J Transplant 2004; 4: 1889-1896
18. Karam G, Maillet F, Parant S et al. Ureteral necrosis after kidney transplantation: Risk factors and impact on graft and patient survival. Transplantation 2004; 78: 725-729
19. Maier U, Madersbacher S, Banyai-Falger S et al. Late ureteral obstruction after kidney transplantation. Fibrotic answer to previous rejection? Transpl Int 1997; 10: 65-68
20. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335-340